Qorvo
QRVO
$106.43
+8.89%
Qorvo, Inc. is a leading semiconductor company specializing in radio frequency (RF) solutions, including filters, power amplifiers, and front-end modules critical for wireless communications. The company operates as a key supplier within the technology sector, serving major smartphone manufacturers as well as diverse markets like wireless infrastructure, cable TV, networking, and defense. The current investor narrative centers on the company's cyclical recovery and margin expansion, as evidenced by a significant year-over-year revenue rebound and improved profitability in its latest quarterly results, positioning it as a play on the stabilization and growth within the smartphone and broader connectivity markets.…
QRVO
Qorvo
$106.43
Related headlines
Investment Opinion: Should I buy QRVO Today?
Rating & Thesis: Hold. QRVO presents a compelling but not yet conclusive recovery story; investors should wait for more consistent execution and clearer signs that the margin expansion is sustainable before establishing new positions, aligning with the prevailing neutral analyst sentiment.
Supporting Evidence: The recommendation is grounded in four key data points: 1) The attractive forward P/E of 11.79x suggests the market is not overpaying for expected growth. 2) Revenue growth has turned positive at 8.36% YoY. 3) Profitability has recovered dramatically, with operating margin leaping from 0.92% to 19.35%. 4) The company generates strong free cash flow ($595M TTM) and has a healthy balance sheet (current ratio 3.24). However, these positives are counterbalanced by high volatility (beta 1.42) and underwhelming relative strength versus the market (-7.55% over one year).
Risks & Conditions: The two biggest risks are a slowdown in smartphone demand reversing revenue growth and a failure to maintain elevated operating margins, leading to multiple compression. This Hold rating would upgrade to a Buy if the stock demonstrates sustained quarterly revenue growth above 10% and holds operating margins above 15% for two consecutive quarters, confirming the recovery's durability. It would downgrade to a Sell if revenue growth turns negative or operating margins fall back below 5%. Relative to its own history and the sector, the stock appears fairly valued, not egregiously overvalued or deeply undervalued.
Sign up to view all
QRVO 12-Month Price Forecast
QRVO is at an inflection point. The fundamental improvement is undeniable, with soaring profitability and returning growth. However, the stock's high volatility, cyclical end-market exposure, and the market's skeptical stance (evidenced by neutral ratings) warrant caution. The forward P/E offers a margin of safety, but the investment thesis hinges on the durability of margin expansion, which has yet to be proven over multiple quarters. The stance would upgrade to Bullish on evidence of sustained margin strength (e.g., two more quarters >18%) and would downgrade to Bearish on any material deceleration in revenue growth or margin contraction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Qorvo's 12-month outlook, with a consensus price target around $138.36 and implied upside of +30.0% versus the current price.
Average Target
$138.36
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$85 - $138
Analyst target range
Analyst coverage for QRVO appears limited, with only 4 analysts providing estimates for future EPS and revenue, and no explicit consensus price target or recommendation distribution provided in the data. The lack of a broad consensus target and the minimal number of analysts suggests this is a stock with limited institutional coverage, which can lead to higher volatility and less efficient price discovery. The available institutional ratings from early 2026 show a pattern of neutral to cautious sentiment, with firms like Barclays, Mizuho, Stifel, Citigroup, Susquehanna, and UBS all issuing 'Neutral', 'Equal Weight', or 'Hold' ratings, while Piper Sandler maintained an 'Overweight'. This pattern indicates that while the fundamental recovery is acknowledged, analysts remain watchful for sustained execution before turning more bullish, contributing to a wide potential range of outcomes absent a clear price target anchor.
Bulls vs Bears: QRVO Investment Factors
The evidence currently favors the bull case, driven by a powerful fundamental recovery in profitability and accelerating revenue growth. The dramatic margin expansion from 0.92% to 19.35% is the strongest single data point, supported by robust free cash flow and a reasonable forward P/E of 11.79x. However, the bear case is supported by significant external skepticism, as evidenced by predominantly neutral analyst ratings and the stock's high volatility and recent underperformance versus the market. The single most important tension in the investment debate is whether the current margin expansion and revenue recovery represent a sustainable new operating paradigm for QRVO or merely a cyclical uptick that will fade, leaving the stock vulnerable to multiple compression given its high beta and cyclical end markets.
Bullish
- Dramatic Profitability Recovery: Net income swung from a loss of -$17.44 million in Q2 FY2025 to a profit of $164.06 million in Q3 FY2026. Operating margin expanded from 0.92% to 19.35% over the same period, demonstrating significant operating leverage as revenue recovers.
- Accelerating Revenue Growth: Latest quarterly revenue grew 8.36% year-over-year to $992.96 million, a stark reversal from prior periods of stagnation and decline. This growth is driven by the core Advanced Cellular Group segment, which generated $690.76 million.
- Strong Free Cash Flow Generation: The company generated $595.20 million in trailing twelve-month free cash flow, translating to a healthy free cash flow yield. This provides financial flexibility for investments, debt reduction, or potential shareholder returns.
- Attractive Forward Valuation: The forward P/E ratio of 11.79x is nearly half the trailing P/E of 21.13x, indicating the market expects substantial earnings growth. This forward multiple is reasonable for a semiconductor company in a cyclical recovery phase.
Bearish
- Limited Analyst Coverage & Sentiment: Only 4 analysts provide estimates, and institutional ratings from early 2026 are predominantly 'Neutral' or 'Hold'. This lack of bullish conviction suggests skepticism about the sustainability of the recovery.
- High Volatility & Market Underperformance: A beta of 1.42 means the stock is 42% more volatile than the market. It has underperformed the SPY by 7.55% over the past year, indicating higher risk without commensurate recent reward.
- Revenue Concentration & Cyclicality: The company's fortunes are heavily tied to the cyclical smartphone market. While diversification exists, a slowdown in smartphone demand could quickly reverse the current 8.36% YoY revenue growth.
- Valuation Normalization Risk: The trailing P/E of 21.13x, while down from a peak of 76.10x, remains elevated compared to the forward multiple. If earnings growth fails to materialize, the stock is vulnerable to multiple compression.
QRVO Technical Analysis
The stock is in a sustained uptrend, evidenced by a 1-year price change of +17.64%, but is currently consolidating after a recent surge. Trading at a price of $92.25, it sits approximately 58% of the way up from its 52-week low of $73.0 towards its high of $106.3, indicating it has recovered meaningfully from lows but is not yet testing new highs, suggesting room for further upside if momentum resumes. Recent short-term momentum is notably strong, with the stock up 13.62% over the past month and 9.25% over the past three months, significantly outpacing the broader market's returns of 5.6% and 8.42% respectively over the same periods, signaling accelerating bullish sentiment. Key technical levels are clearly defined, with immediate support at the 52-week low of $73.0 and resistance at the 52-week high of $106.3; a decisive breakout above $106.3 would signal a resumption of the primary uptrend, while a breakdown below $73.0 would invalidate the recovery thesis. The stock's beta of 1.42 indicates it is 42% more volatile than the SPY, which is important for risk-aware investors as it implies larger price swings in both directions.
Beta
1.42
1.42x market volatility
Max Drawdown
-22.0%
Largest decline past year
52-Week Range
$73-$106
Price range past year
Annual Return
+39.9%
Cumulative gain past year
| Period | QRVO Return | S&P 500 |
|---|---|---|
| 1m | +25.2% | +4.8% |
| 3m | +29.4% | +8.2% |
| 6m | +30.3% | +13.1% |
| 1y | +39.9% | +27.9% |
| ytd | +23.4% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QRVO Fundamental Analysis
Revenue growth has turned positive and is accelerating, with the most recent quarterly revenue of $992.96 million representing a solid 8.36% year-over-year increase, a stark improvement from the prior year's periods of stagnation and decline. This growth is being driven by the company's largest segment, ACG (Advanced Cellular Group), which contributed $690.76 million in the latest period, alongside contributions from HPA (High Performance Analog) at $190.90 million and CSG (Connectivity and Sensors Group) at $111.30 million. Profitability has recovered dramatically, with net income of $164.06 million in Q3 FY2026 and a gross margin of 46.75%, up from a net loss of -$17.44 million and a gross margin of 42.55% in the year-ago quarter (Q2 FY2025), demonstrating significant margin expansion. The operating margin for the latest quarter was 19.35%, a substantial improvement from 0.92% a year ago, indicating effective cost management and operating leverage as revenue recovers. The balance sheet is healthy with a strong current ratio of 3.24 and a manageable debt-to-equity ratio of 0.46, providing financial flexibility. The company is generating robust free cash flow, with TTM free cash flow of $595.20 million, translating to a healthy free cash flow yield, and an ROE of 10.14%, indicating efficient use of shareholder equity to generate profits.
Quarterly Revenue
$992959000.0B
2025-12
Revenue YoY Growth
+0.08%
YoY Comparison
Gross Margin
+0.46%
Latest Quarter
Free Cash Flow
$595202000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QRVO Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 21.13x, while the forward PE is significantly lower at 11.79x, indicating the market expects a substantial increase in earnings over the next twelve months. Compared to sector averages implied by its current metrics, the stock's trailing PE of 21.13x and PS ratio of 1.95x appear reasonable for a semiconductor company showing accelerating growth and margin recovery. The forward PE discount to the trailing multiple suggests the market has already priced in the earnings recovery but may see further upside if execution continues. Historically, the stock's own trailing PE has fluctuated wildly, from deeply negative during loss-making periods to as high as 76.10x in Q1 FY2026; the current 21.13x is well below that recent peak and aligns more closely with its profitable historical periods (e.g., 12.18x in Q3 FY2026 per historical data), suggesting the valuation has normalized alongside fundamentals and is not stretched.
PE
21.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -144x~6690x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: QRVO's primary financial risk is its dependence on continued revenue growth to justify its valuation, as the forward P/E of 11.79x embeds significant earnings expansion expectations. A deceleration from the current 8.36% YoY growth rate could trigger a re-rating. While the balance sheet is strong with a 0.46 debt-to-equity ratio, the company operates in the capital-intensive semiconductor sector, and any downturn could pressure its robust $595M TTM free cash flow. Furthermore, revenue concentration in the Advanced Cellular Group (69.6% of last quarter's sales) creates operational risk tied to the health of a few major smartphone customers.
Market & Competitive Risks: The stock trades at a 42% premium to market volatility (beta of 1.42), making it highly sensitive to sector rotations and growth stock sell-offs. Its current price sits 58% of the way from its 52-week low to high, indicating it has priced in much of the recovery, leaving limited margin for error. Competitive disruption in the RF semiconductor space is a constant threat, and the lack of a broad analyst consensus (only 4 covering) contributes to price discovery inefficiency and potential for sharp swings on news. The recent pattern of neutral institutional ratings suggests the market remains unconvinced of a durable turnaround.
Worst-Case Scenario: The most damaging scenario would be a combination of a cyclical downturn in smartphone demand coinciding with a broader market correction for growth stocks. This could halt the revenue recovery, reverse margin gains, and compress the forward P/E multiple towards single digits. In this adverse scenario, the stock could realistically retest its 52-week low of $73.0, representing a downside of approximately -21% from the current price of $92.25. The historical max drawdown of -21.97% provides a similar magnitude for potential loss, aligning with this downside target range.
FAQ
The key risks are, in order of severity: 1) Cyclical Demand Risk: Revenue is heavily tied to the smartphone cycle; a downturn could reverse the current 8.36% growth. 2) Volatility Risk: A beta of 1.42 means larger price swings than the market, amplifying losses in downturns. 3) Execution Risk: The dramatic margin expansion to 19.35% must be sustained; any slippage would hurt the valuation. 4) Sentiment Risk: With only 4 analysts covering and most ratings neutral, the stock lacks a bullish catalyst from Wall Street, which can limit upside momentum.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $92 and $100 as the recovery continues moderately. The Bull Case (30% probability) targets a breakout to $106.3-$115 on accelerated growth and sustained high margins. The Bear Case (20% probability) warns of a pullback to the $73-$85 range if the recovery falters. The Base Case is most likely, assuming the company meets current expectations for single-digit growth and maintains improved profitability. The key assumption is that operating margins remain in the high-teens.
QRVO appears fairly valued relative to its recovery prospects. The trailing P/E of 21.13x is elevated but reflects past earnings; the more informative forward P/E of 11.79x suggests the market is paying a reasonable price for expected growth. This multiple is not stretched compared to sector peers, especially given the company's 46.75% gross margin and strong free cash flow generation. The valuation implies the market expects the recent earnings recovery to continue but is not pricing in perfection, leaving room for upside if execution beats expectations or downside if it disappoints.
QRVO is a conditional buy for investors with a higher risk tolerance and a medium-term horizon. The stock offers a reasonable forward P/E of 11.79x based on a compelling profitability recovery, with operating margin jumping to 19.35%. However, its high beta of 1.42 means it will be more volatile than the market, and it has underperformed the SPY over the past year. It is a good buy for those who believe the margin expansion is sustainable and are willing to accept the cyclical risks of the semiconductor industry. For more conservative investors, it is prudent to wait for more consistent quarterly execution.
QRVO is more suitable for a medium to long-term investment horizon of 12-24 months, not short-term trading. The thesis is based on a cyclical business recovery playing out over several quarters, requiring time for execution to be validated. The stock does not pay a dividend, eliminating an income reason for holding. Its high beta of 1.42 makes it risky for short-term trades, as news-driven volatility can lead to significant swings. Investors should be prepared to hold through potential volatility to capture the full value of the operational turnaround, with a suggested minimum holding period of one year.